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The podovirus P22, which infects O-antigen strains of Salmonella, incorporates a dsDNA translocating channel (portal dodecamer) at a unique
vertex of the icosahedral capsid. The portal subunit (gp1, 82.7 kDa) exhibits multiple S–H⋯X hydrogen bonding states for cysteines 153, 173, 283
and 516 and these interactions are strongly perturbed by portal ring formation. Here, we analyze in vivo activities of wild type (wt) and Cys→Ser
mutant portals, demonstrate that in vivo activity is correlated with in vitro assembly kinetics, and suggest mechanistic bases for the observed
assembly defects. The C283S portal protein, which assembles into rings at about half the rate of wt, exhibits significantly diminished infectivity
(∼50% of wt) and manifests its defect prior to DNA packaging, most likely at the stage of procapsid assembly. Conversely, the C516S mutant,
which assembles at twice the rate of wt, is more severely deficient in vivo (∼20% of wt) and manifests its defect subsequent to capsid maturation
and DNA packaging. Both C153S and C173S portals function at levels close to wt. The results suggest that C283S and C516S mutations may be
exploited for improved characterization of the folding and assembly pathway of P22 portal protein.
© 2007 Elsevier Inc. All rights reserved.Keywords: Bacteriophage; P22; Portal; Protein; Structure; Assembly; Function; Raman spectroscopyIntroduction
P22 is a member of the Podoviridae family of short-tailed
bacteriophages that infect strains of Salmonella typhimurium
presenting a repetitive O-antigen structure along the lipopoly-
saccharide surface. The mature phage consists of a 43.4-kbp
dsDNA genome packaged within an icosahedral capsid
comprising 420 copies of a 46.8-kDa coat protein (gp5), 12
copies of an 82.7-kDa portal protein (gp1), 3 to 12 copies of eachAbbreviations: dsDNA, double-stranded deoxyribonucleic acid; EDTA,
ethylenediaminetetraacetic acid; EM, electron microscopy; gp, gene product;
HPSEC, high performance size exclusion chromatography; IPTG, isopropyl-β-
D-thiogalactopyranoside; kbp, kilo base pair; kDa, kilo Dalton; MDa, mega
Dalton; SDS–PAGE, sodium dodecyl sulfate polyacrylamide gel electrophor-
esis; SE, sedimentation equilibrium; SEC, size exclusion chromatography; SH,
sulfhydryl; t1/2, half-life; Tris, tris(hydroxymethyl)aminoethane; UV, ultraviolet;
wt, wild type.
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doi:10.1016/j.virol.2007.02.040of three ejection proteins (gp7, 23.4 kDa; gp16, 6.4 kDa; gp20,
50.1 kDa) and three portal completion proteins (gp4, 18.0 kDa;
gp10, 52.5 kDa; gp26, 24.7 kDa), and 6 tailspikes, each formed
from 3 copies of a 71.9-kDa subunit (gp9) (King et al., 1973;
Botstein et al., 1973; Prevelige and King, 1993; Fane and
Prevelige, 2003; Casjens and Weigele, 2005). The portal
dodecamer, which is located at a unique fivefold vertex of the
T=7 icosahedral capsid, has been considered pivotal to many
steps in virion assembly, including construction of the capsid
precursor shell (procapsid) (Bazinet et al., 1988; Bazinet and
King, 1988; Greene and King, 1996; Moore and Prevelige,
2002a; Weigele et al., 2005), reorganization of the procapsid
lattice during maturation (Moore and Prevelige, 2002a, 2002b),
packaging of the viral genome (Casjens et al., 1992; Moore and
Prevelige, 2002b), closure of the portal channel and attachment
of the tail apparatus (Strauss and King, 1984; Tang et al., 2005).
Molecular mechanisms governing the morphogenesis of
bacteriophage P22 provide useful prototypes for understanding
assembly pathways of many eukaryotic dsDNA viruses,
including the Herpesviridae (Newcomb et al., 2003; Trus et
337Y. Sun et al. / Virology 365 (2007) 336–345al., 2004). An overview of the P22 assembly pathway is
represented schematically in Fig. 1. Roles of scaffolding and
capsid proteins in this pathway have been extensively
investigated; however, the role of the portal remains less well
understood.
The portal subunit contains 725 amino acids, including four
cysteines that are widely distributed through the sequence (Cys
153, Cys 173, Cys 283, Cys 516) (Eppler et al., 1991).
Although no high-resolution structure is currently available for
either the isolated gp1 subunit or its oligomeric ring, the
secondary and tertiary structures of gp1 monomers and rings
were characterized previously by methods of Raman spectro-
scopy (Rodriguez-Casado et al., 2001). In addition, the S–H⋯X
hydrogen bonding states of the four cysteines were identified
as a function of in vitro ring assembly (Rodriguez-Casado and
Thomas, 2003). The P22 portal assembly has been character-
ized as a dodecamer based on both negative-stain electron
microscopy (EM) of rings produced in vitro (Bazinet et al.,
1988) and cryo-EM reconstructions of tails in situ (Lander et
al., 2006) or extracted from mature virions (Tang et al., 2005).
A preliminary crystallographic analysis of the portal dodeca-
mer has also been reported (Cingolani et al., 2002). Very
recently, it has been shown that both undecameric and
dodecameric ring states of the P22 portal protein are stable
in vitro (Poliakov et al., 2007).
Our previous Raman studies have shown that local
environments of many gp1 side chains, including cysteines,
tyrosines and tryptophans, are altered dramatically by ring
formation even though very little overall change occurs in the
ordered secondary structure of the subunit (∼57% α-helix,Fig. 1. P22 assembly pathway showing procapsid formation involving coat, scaffol
procapsid interior concurrent with DNA packaging and shell expansion (right, top-to-
tailspikes to the mature capsid (bottom, right-to-left) (King et al., 1976; Fane and P∼26% β-strand) (Rodriguez-Casado et al., 2001; Rodriguez-
Casado and Thomas, 2003). The data suggest domain move-
ments involving much of the protein, including a portion of the
sequence (residues 240–350) that exhibits secondary structure
homology with residues 125–225 of the bacteriophage φ29
portal (connector) (Simpson et al., 2000; Rodriguez-Casado
et al., 2001). In the φ29 connector crystal structure the latter
sequence contributes to the surfaces of the DNA-translocating
channel and subunit interface. Although only one cysteine of
the P22 portal subunit (Cys 283) occurs within the putative
homology domain, side-chain interactions of all four cysteines
are demonstrably sensitive to the state of portal assembly.
Specifically, all cysteines exhibit stronger S–H⋯X hydrogen
bonding interactions in the monomer than in the dodecamer
(Rodriguez-Casado and Thomas, 2003). A preliminary analysis
of the in vitro assembly defects of the Cys→Ser mutants has
been reported (Rodriguez-Casado and Thomas, 2003).
Here, we present a more detailed quantitative assessment of
portal assembly kinetics using size exclusion chromatography
(SEC) for the wt and Cys→Ser mutant proteins, report the
relative infectivities of virions incorporating wt and mutant
portals, and demonstrate that the in vitro portal assembly
defects correlate with in vivo phage activity. We also present the
results of sedimentation equilibrium measurements on wt and
mutant portals, which extend previously reported measurements
on the wt monomer (Moore and Prevelige, 2001). The
correlations established here may provide benchmarks for
future assessment of portal protein interactions with other phage
structural proteins that participate in late stages of the virion
assembly pathway (Fig. 1).ding and portal subunits (top, left-to-right). Scaffolding is eliminated from the
bottom). Subsequent steps involve attachment of portal completion proteins and
revelige, 2003).
Table 1
Relative biological activities of wt and Cys→Ser mutant portal rings a
Portal 28 °C 37 °C 42 °C 45 °C
wt 100 100 100 60
C153S 70±4 71±4 69±4 43±4
C173S 72±4 70±4 71±4 42±4
C283S 48±4 47±4 49±4 30±2
C516S 19±2 18±2 5±1 2±1
a
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Oligomerization rates of portal variants
The well-resolved HPSEC elution peaks of portal protein
monomer and dodecamer (Fig. 2A, insert) and the readily
monitored time dependencies of their HPSEC elution profiles
(Fig. 2A and corresponding data on C153S and C173S notFig. 2. (A) HPSEC profiles of the monomer→dodecamer oligomerizations of
wt (top), C283S (middle) and C516S (bottom) portals. In each case, the
monomer and dodecamer elution volumes are at 18.3 and 15.5 mL, respectively.
For wt, the chromatograms were recorded at 0, 1, 3, 5, 7, 9, 12, 18, 22, 27, 32, 40
and 51 h after incubation of a 50 μg/μL solution at 4 °C. (The inset at upper left
shows the 40-h chromatogram trace, in which the relative peak areas correspond
to 52%monomer and 48% dodecamer.) For C283S, data are shown for 0, 1, 2, 3,
4, 7, 9, 12, 16, 20, 26, 32, 42, 50, 63 and 79 h. For C516S, data are shown for 0,
1, 2, 3, 4, 6, 9, 14, 20, 26, 29, 35 and 44 h. (B) Rates of oligomerization of wt and
Cys→Ser mutant portals, as labeled.
Entries are the percentages of wt activity (arbitrarily 100% for the
recombinant His6-tagged protein at 37 °C), as measured by the number of
PFUs in complementation assays at the indicated growth temperatures.
Protocols are described in the text. As shown previously (Moore and Prevelige,
2001), the recombinant His6-tagged protein exhibits 50% of the activity of the
native wild type sequence.shown) provide a basis for accurate evaluation of in vitro portal
assembly rates (Fig. 2B). The data shown in Fig. 2, which were
collected from 50 μg/μL protein solutions in buffer A at 4 °C, are
consistent with the kinetics data reported previously for wt portal
assembly within the temperature interval 15–30 °C (Moore and
Prevelige, 2001). We employed 4 °C here to decelerate the
dodecamerization reaction and enable more precise measure-
ment of the gp1 assembly rate. Importantly, the present results
refine the previously proposed rough estimates of mutant
assembly kinetics in low salt buffer (Rodriguez-Casado and
Thomas, 2003), where competing disassembly events were not
explicitly taken into account. The precision of the results shown
in Fig. 2B permits a clear-cut distinction between mutant portals
(C153S and C173S) that exhibit assembly rates very similar to
wt and those (C283S and C516S) that exhibit highly disparate
assembly rates. The times required for 50% assembly of each
portal variant at the in vitro conditions specified in the Fig. 2
legend are as follows: t1/2
wt =42 h, t1/2
C153S =44 h, t1/2
C173S =36 h,
t1/2
C283S =90 h, t1/2
C516S =20 h. Thus, the C283S mutation sig-
nificantly impedes in vitro assembly, presumably by hyperst-
abilizing the monomer state, while the C516S mutation has the
reverse effect. All variants achieve >95% assembly, as verified
by SEC after incubation of the monomer at 22 °C for 24 h.
The isosbestic points evident in the data of Fig. 2A (and in
additional data on C153S and C173S not shown) demonstrate
that in vitro assembly of each portal variant occurs without
significant accumulation of intermediates along the assembly
pathway. This finding is of relevance to the Raman experiments
described below, for which identical protein concentrations of
50 μg/μL were employed.
Biological activities of portal variants
Assessment of the relative biological activities of wt and
Cys→Ser mutant portals expressed in vivo from inducible
plasmids indicates that only the mutants C283S and C516S
exhibit activities less than 50% that of wt (Table 1). Biological
activities were monitored using complementation assays in
which S. typhimurium cells containing the gp1 expressing
plasmid were infected with 1−13− amber mutant phage and
simultaneously induced to express gp1. The cultures were
grown at 37 °C, which is optimal for S. typhimurium cells and
P22 phage. Activities were quantified in terms of the number of
Fig. 3. SDS–PAGE detection of portal protein in sucrose gradient fractions of
the cell lysates obtained from complementation assays for wt, C173S, C283S
and C516S portal variants. (Results for the C153S variant, not shown, are
similar to those shown for wt, C173S and C516S variants.) In the top gel, which
corresponds to wt, molecular weight standards are shown in the lane to the left of
lane 1; the lanes labeled 1–12 correspond to fractions containing species of
increasing sedimentation coefficient; the fractions containing DNA-free
procapsids and DNA-filled capsids are labeled PC and φ, respectively; and
bands of the portal (gp1), coat (gp5) and scaffolding (gp8) proteins are indicated
by the labels at the right (Fuller and King, 1980; Moore and Prevelige, 2001).
The same gel assignments apply to the mutants.
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lysates. The results, as listed in Table 1, indicate modest activity
defects (∼30%) for C153S and C173S, compared with the more
serious defects for C283S (53%) and C516S (82%). We
conclude that a Ser substitution for Cys 283 or Cys 516
seriously impairs portal function. The corresponding in vitro
studies noted above imply that the in vivo defects occur at the
level of monomer→dodecamer assembly kinetics.
Additional complementation assays revealed that all portal
protein present in each cell lysate was expressed from the
inducible plasmid and not from the P22 genome. For such
controls, which produced no phage, the host was infected with
1−13− phage but not induced to express gp1. On the basis of
these findings, we conclude that in each infection (wt, C153S,
C173S, C283S, C516S) all of the gp1 available for virion
assembly was induced from the gp1-expressing plasmid.
Therefore, the biological activities determined in the comple-
mentation assays of Table 1 reliably quantify in vivo activities
of the portal variants.
Molecular basis of mutant portal defects
To gain further insight into the likely sources of the
infectivity defects exhibited by P22 particles incorporating the
different portal variants, we examined soluble components of
the respective cell lysates using sucrose gradient analysis and
SDS–PAGE. Previous analyses of lysates of P22-infected cells
using similar methods (Fuller and King, 1980; Moore and
Prevelige, 2002b) provide a basis for distinguishing mature
virions (DNA-filled capsids, bottom of gradient) from
procapsids or procapsid-like particles (devoid of DNA, middle
of gradient). Fig. 3 compares the results obtained for wt,
C173S, C283S and C516S. (Not shown are the results
obtained for C153S, which are indistinguishable from wt.)
Lanes 7, 8 and 9 of each gel of Fig. 3 show electrophoresis
patterns of middle gradient fractions 7, 8 and 9, respectively,
which contain the bulk of procapsids and procapsid-like
species. Lanes 7, 8 and 9 of the wt gel (Fig. 3, top) clearly
reveal that gp1 (portal), gp5 (coat) and gp8 (scaffold) are the
most abundant protein components, as expected for native P22
procapsids. These particles are competent to package DNA
and lead to the bottom gradient fraction (lane 12) that is
dominated by gp1 and gp5. (See also Fig. 3 legend.) Similar
results apply to C173S (Fig. 3, second from top), C516S (Fig.
3, bottom) and C153S (not shown). On the other hand, the
corresponding lanes of the C283S gel (Fig. 3, second from
bottom) are relatively deficient in the portal protein gp1,
despite abundant populations of gp5 and gp8, thus signaling
the presence of a substantial proportion of procapsid-like
particles lacking portal. It is clear from lane 12, however, that
a significant population of native C283S procapsids was also
formed and underwent DNA packaging. We conclude that the
Cys 283→Ser mutation introduces an assembly defect in vivo
at the level of portal incorporation into the procapsid, and that
this defect diminishes but does not totally preclude the
formation of a subpopulation of native procapsids competent
to package DNA. Because C283S portal protein dodecamer-ization in vitro is appreciably retarded vis-à-vis wt (Fig. 2), it
seems likely that the C283S mutation introduces a kinetic
barrier to portal ring formation in vivo.
Table 2
Thermostabilities of capsid-incorporated wt and Cys→Ser mutant portal rings a
Portal 45 °C, 5 h 45 °C, 15 h 55 °C, 5 h 55 °C, 15 h
wt 92±10 97±4 104±6 97±8
C153S 99±9 93±9 107±5 97±13
C173S 92±4 93±4 104±9 91±10
C283S 110±8 93±9 101±12 97±7
C516S 95±5 88±9 80±5 29±4
a Entries are the percentages of wt activity (arbitrarily 100% for phage
incubated 15 h at 4 °C), as measured by the number of PFUs following
incubation at the indicated temperatures and times. All phages were grown by
complementation at 37 °C, as described in the text.
Fig. 5. Sedimentation equilibrium analysis of the wt portal dodecamer, obtained
from protein solutions of 0.3 mg/mL (open circles) and 0.6 mg/mL (filled
circles) concentrations spinning at 4000 RPM for 24 h. Data points were
globally fitted to a single ideal solute model and the fit is shown as a continuous
line through the data points. The residuals for the 0.3 mg/mL solution are shown
at the top. As judged from the random distribution of residuals, the single ideal
solute model produces a reasonably good fit to the experimental data.
340 Y. Sun et al. / Virology 365 (2007) 336–345The gel pattern of C516S (Fig. 3, bottom) is similar to wt
(Fig. 3, top), indicating a native-like distribution between
procapsids and mature virions. Yet C516S represents a mutation
that greatly accelerates portal assembly in vitro (Fig. 2) and
generates virions of severely compromised infectivity. Hyper-
assembly of the C516S portal evidently has no significant
impact on either portal incorporation into procapsids or
competency to package DNA. We speculate that the in vivo
phenotype of C516S arises from a defective post-packaging
event. Plausible defects are improper attachment of one or
more proteins required for a fully functional tail apparatus
(gp4, gp10, gp26 and/or gp9), unproductive release of DNA
due to non-native interactions of the mutant portal with
ejection proteins (gp7, gp16 and/or gp20) or failure of the
C516S portal to achieve the conformation competent for
DNA release from the capsid.
Thermostabilities of capsid-incorporated portal variants
The results of complementation assays of wt and mutant
portals at different growth temperatures (28, 37, 42 and 45 °C)
are compared in Table 1. In vivo activities of wt, C153S, C173S
and C283S are essentially unchanged between 28 and 42 °C,
then fall precipitously at 45 °C. On the other hand, the in vivo
activity of C516S falls consistently between 37 and 45 °C. We
infer from these results that the in vivo folding/assembly
pathway of the C516S mutant is uniquely temperature-sensitive
between 37 and 42 °C. Evidently, the relatively weak and
temperature-independent S–H⋯X hydrogen bonding interaction
of Cys 516 in the wt structure is not sustained by O–H⋯X
interaction of Ser 516 in the mutant.
The P22 variants produced at 37 °C via the complementa-
tions described above were also incubated at 4, 45 and 55 °C toFig. 4. Negative-stain electron micrographs (60,000×) of wild-type and mutant portal
a size marker were deposited on copper grids, fixed with 1.0% formaldehyde and stassess in vitro thermostabilities of the capsid-incorporated
portals. The number of viable phage remaining after incubation
periods of 5 and 15 h was determined by titering (Table 2).
Again, we find that only C516S exhibits a significant
compromise of activity with temperature, i.e. greatly diminished
stability at the highest temperature tested (55 °C).
These results provide further evidence of the importance of
the Cys 516 side chain for portal assembly and function.
Portal morphology
The ability of each gp1 mutant to form a portal ring assembly
in vitro was assessed by electron microscopy. Fig. 4 compares
negative stain images of in vitro-assembled wt and mutant
portals. At this resolution, wt and mutants are indistinguishable
from one another and from selected images published
previously (Rodriguez-Casado and Thomas, 2003). Although
earlier attempts to visualize C173S and C283S portals were not
successful, owing to apparent disassembly of the rings in the
low salt buffer previously employed (Rodriguez-Casado and
Thomas, 2003), they are shown here to exhibit the same sizes. Portal solutions (0.05 μg/μL in buffer A) containing P22 phage (∼1011/mL) as
ained with 2% uranyl acetate.
Table 3
Molecular weights of wt and Cys→Ser mutant portal rings determined by
sedimentation equilibrium analytical ultracentrifugation a






a Each molecular weight is the average of six independent determinations.
Fig. 6. (A) Raman spectra of wt and Cys→Ser mutant portal dodecamers in the
region of cysteine SH stretching vibrations (2520–2620 cm−1). Spectra were
excited at 532 nm from 50 μg/μL solutions maintained at 4 °C. Further details of
data collection are given in the text. (B) The Raman SH signature specific to
each cysteine of the wt dodecamer, obtained by subtracting the appropriate
mutant spectrum from the wt spectrum. (C) The upper trace shows the
experimentally observed Raman spectrum of the wt portal dodecamer (from
panel A) and the lower trace shows the spectrum computed by summing the four
mutant spectra (from panel B). The close correspondence between the observed
and computed spectra is consistent with the absence of coupling between the
hydrogen bonding states of individual cysteines in the portal dodecamer.
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medium of buffer A stabilizes all of these portal variants.
Shape-independent determination of the molecular weight of
each portal assembly shown in Fig. 4 was carried out by
sedimentation equilibrium (SE) analysis. Representative data
(A280 vs. radius) collected fromwt portal solutions of 0.3 mg/mL
and 0.6 mg/mL are shown in Fig. 5. The calculated molecular
weights and standard deviations for six independent runs on
each portal variant are listed in Table 3. These results indicate
essentially identical molecular masses for monodisperse wt and
mutant portals within the limits of experimental error. The mean
molecular mass (1.011±0.005 MDa) is compatible with a 94%
or greater dodecamer population. The experimental result is also
consistent with the calculated molecular mass of a His6-tagged
dodecamer (1.0057 MDa).
Recently, Poliakov and coworkers have reported experi-
mental conditions under which the P22 portal co-populates
both dodecameric and undecameric states (Poliakov et al.,
2007). Our measurements do not preclude the presence of a
minor component of portal 11-mers, but suggest that at the
experimental conditions employed here the 12-mer ring
predominates.
Cysteine Raman signatures of portal variants
In a previously published analysis of the cysteine Raman
signatures of wt and mutant portal rings it was concluded that
mutation of one Cys site affected the local environments of
other Cys sites (Rodriguez-Casado and Thomas, 2003). We
have now determined that this unexpected result was due to
inhomogeneities in the specific samples examined, namely the
simultaneous presence of both monomers and oligomers in the
C153S, C173S and C283S preparations subjected to Raman
analysis. The coexistence of monomer and oligomer in each
case was due to partial dissociation of the latter at the relatively
low salt concentration employed (∼100 mM NaCl). Here, we
show the Raman results for purified homogeneous preparations
of oligomeric portals stabilized in the ring form by elevation of
the salt concentration (∼400 mM NaCl) (Fig. 6). Oligomer
stability in each case was confirmed by HPSEC analyses both
before and after the Raman data collections.
The cysteine Raman spectra (2520–2620 cm−1) of the portal
variants are compared in Fig. 6A and the Raman signature of
each cysteine site obtained by spectral subtraction is shown in
Fig. 6B. Each signature reveals two S–H markers. These occur
at 2565 and 2587 cm−1 and are diagnostic of moderately strong
Table 4
Sulfhydryl Raman markers and S–H⋯X hydrogen bond strengths of portal
cysteines a




C153 2565 (80%) Moderate
2587 (20%) Very weak
C173 2565 (24%) Moderate
2587 (76%) Very weak
C283 2565 (60%) Moderate
2587 (40%) Very weak
C516 2565 (50%) Moderate
2587 (50%) Very weak
a Data are for dodecameric portal rings in 400 mM NaCl solutions. Each
cysteine gives rise to two distinct Raman markers at the indicated wavenumber
values (cm−1 units). In each case the relative intensity distribution (%) and
diagnostic hydrogen bonding states are indicated (Li and Thomas, 1991).
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in the latter category are cysteines for which the SH group is
exposed to solvent H2O (Li and Thomas, 1991). The results
demonstrate that each SH side chain of the wt portal protein
participates in two types of hydrogen bonding interactions in the
dodecamer, and that the population distribution is specific to the
cysteine site. The population distributions, estimated on the
basis of integrated band intensities (Li and Thomas, 1991; Raso
et al., 2001), are listed in Table 4. The occurrence of multiple
S–H⋯X states for a single cysteinyl side chain in a mono-
disperse protein assembly is not unprecedented and has been
reported for cysteines of the native P22 tailspike trimer (Raso
et al., 2001). The rank order of increasing average hydrogen
bond strength in the wt portal is C173<C516<C283<C153.
Fig. 6C compares the experimentally measured cysteine
Raman spectrum of wt portal with that generated by summing
the contributions from all individual cysteines (Fig. 6B). The
excellent agreement between the experimental spectrum and the
summation shows that the hydrogen bonding properties of all
cysteine sites are mutually independent, as long as the integrity
of each monodisperse portal is maintained (achieved here by
stabilization in high salt buffer, 400 mM NaCl).
Discussion and conclusions
The portal of P22 is involved in key events of virion
assembly and function, including the formation of a properly
dimensioned procapsid shell and the translocation of the
dsDNA genome into and out of the viral capsid during
packaging and ejection, respectively. These and related func-
tions require a stable dodecameric ring (Lander et al., 2006). In
the present work we have: (i) applied HPSEC methods to
recombinant wt and Cys→Ser mutant portals to assess the roles
of subunit cysteines in dodecamer formation in vitro; (ii) used
complementation assays on 1− amber mutant P22-infected
Salmonella cells to quantify the biological activity of wt and
mutant portal dodecamers in vivo; (iii) used sucrose gradient
separation and SDS–PAGE to characterize the composition of
the cell lysate obtained from each complementation assay;
(iv) monitored sedimentation equilibrium profiles to demon-strate that all cysteine variants of the portal form oligomeric
rings of the same molecular mass (∼1.006 MDa, implying a
dodecamer in each case); and (v) re-examined Raman spectra of
the wt and mutant portals to characterize local structural
environments of the subunit cysteines. We have found that the
dodecamer of each variant, once formed, is highly stable in
400 mM NaCl solution and is readily visualized by negative
stain EM as a ring of ∼20 nm outer diameter (Fig. 4). We have
also found that the C283S and C516S mutants are seriously
defective vis-à-vis the wt portal with regard to both in vitro
assembly kinetics and in vivo activity. Conversely, the C153S
and C173S mutants are similar to wt in both kinetics of
dodecamer formation and biological activity. We conclude that
in vitro assembly defects and in vivo activity defects of
Cys→Ser portal mutants are closely correlated.
The Cys→Ser mutation at 283 generates two distinguish-
able functional defects vis-à-vis wt, namely retarded assembly
kinetics in vitro and seriously reduced virion activity in vivo.
The activity defect likely relates to portal incorporation during
procapsid assembly. The stability of the C283S dodecamer is
also somewhat compromised in low salt solution (Rodriguez-
Casado and Thomas, 2003), which suggests a surface location
that is impacted by the different hydrogen-bonding capabilities
of SγH and OγH. Interestingly, a comparative analysis of the
phage P22 and φ29 portal subunit sequences (Rodriguez-
Casado et al., 2001; Simpson et al., 2000) suggests that residue
283 is within a segment of the polypeptide chain that
participates in intersubunit interactions. Accordingly, the
present results suggest that Cys 283, by virtue of its moderate
and very weak Sγ–H⋯X hydrogen bonding properties, plays a
key role in subunit–subunit interactions leading to dodecamer
formation and stabilization.
The Cys→Ser mutation at 516 impairs at least three
functional characteristics of the P22 portal: (i) abnormally
rapid dodecamerization kinetics in vitro, (ii) the most severely
compromised in vivo activity of all mutants investigated (less
than 20% of wt at 37 °C) and (iii) diminished thermal stability
relative to wt when incorporated into the mature virion.
Accordingly, for C516S as for C283S, we observe both in vivo
and in vitro defects. The two variants are distinguished by the
fact that while the in vivo defect of C283S is expressed at the
stage of procapsid assembly, that of C516S is exhibited
subsequent to DNA packaging. On the basis of the hyper-
assembly rate of C516S, we speculate that proper control of
dodecamerization kinetics requires participation of the Cys
516 side chain, possibly through Sγ–H⋯X hydrogen bonding
(which is demonstrably weaker in the dodecamer than in the
monomer). Introduction of the more robust Oγ–H⋯X hydro-
gen bonding potential of Ser 516 presumably compromises the
essential rate-controlling role of Cys 516. Although incorpora-
tion into the procapsid and packaging of DNA are both
enabled in vivo by the C516S portal, the majority of particles
thus formed are defective at a subsequent stage of the P22 life
cycle. Finally, because the C516S mutation thermally
destabilizes the population of mature virions into which it
has been incorporated (Table 2), we also regard Ser 516
substitution as detrimental to thermostabilization of the mature
343Y. Sun et al. / Virology 365 (2007) 336–345virion. Evidently, Cys 516 is an important contributor to virion
stability.
In summary, we interpret the present results as evidence that
the adverse effects of the C283S and C516S mutations are due
primarily to localized structural perturbations within the portal
subunit rather than to global conformational changes or domain
rearrangements. These localized perturbations significantly
impact quaternary interactions (dodecamer assembly), but do
not appreciably perturb overall subunit secondary structure
(Rodriguez-Casado and Thomas, 2003). Consistent with this
interpretation are the data of Fig. 6C, which show that a point
mutation (Cys→Ser) at any one of the four cysteine sites does
not compromise the hydrogen bonding states of the remaining
three non-mutated sites. The fact that the mutation of one portal
cysteine does not alter interactions of others is also in accord
with findings reported previously for the P22 tailspike protein
(Raso et al., 2001). Interestingly, the defects of the portal
mutations studied here are manifested with the same order of
impact in vitro (dodecamer assembly kinetics) and in vivo
(compromised complementation), namely, C516S>C283S>
C173S≈C153S/wt. We conclude that Cys 283 and Cys 516
participate in specific and distinct assembly-related functions
that are crucial to the P22 life cycle.
Materials and methods
Expression and purification of wt and mutant (Cys→Ser)
portal proteins
P22 gene 1, which was modified to express a Leu-Glu linker
and C-terminal His6 tag, was ligated into a pET-21b plasmid and
transformed into Escherichia coli BL21(DE3) cells (gift of
Prof. Peter E. Prevelige, Jr., University of Alabama, Birming-
ham) (Moore and Prevelige, 2001). The product of this
expression system is referred to as the wild-type (wt) protein.
The expression systems for all mutants (C153S, C173S, C283S
and C516S) were developed in our laboratory from the wt
plasmid (Rodriguez-Casado and Thomas, 2003). The wt and
mutant portal proteins were expressed and purified using Ni-
affinity and anion exchange chromatographies, as described
(Moore and Prevelige, 2001; Rodriguez-Casado et al., 2001;
Rodriguez-Casado and Thomas, 2003). The protein eluted from
the Ni column (HiTrap Chelating HP, Amersham Biosciences,
Piscataway, NJ) was prepared in a buffer solution of 100 mM
NaCl, 10 mM EDTA, 20 mM β-mercaptoethanol, 20 mM Tris,
pH 7.9, and applied to the exchange column (HiTrap Q,
Amersham Biosciences). Elution in a NaCl gradient allowed
separation of the monodisperse monomer from oligomers of
various sizes. The homogeneity of the monomer was verified by
high performance size exclusion chromatography (HPSEC)
using two SEC columns in series (model TSK6000 PWxl,
TosoHaas, Montgomeryville, PA and model 330SW, Waters,
Milford, MA, respectively) coupled to an AKTA protein
purification system (Amersham Biosciences). Monomers and
oligomers were also distinguished by dynamic light scattering
measurements (data not shown). As demonstrated previously
(Moore and Prevelige, 2001), the use of tandemly arrangedcolumns resulted in complete separation of the portal monomer.
On the basis of a gp1 molar extinction coefficient of
99,740 M−1 cm−1 at 280 nm, each 250-mL culture typically
produced ∼15 mg (wt, C283S) or ∼5 mg (C153S, C173S,
C516S) of the portal protein.
The portal monomers were brought to a concentration of
∼0.5 mg/mL (6 μM) in 440 mM NaCl, 20 mM Tris, pH 7.5
(buffer A), and stored at −80 °C. At these conditions, all of the
mutant monomers exhibited robust stability and demonstrated
efficient oligomerization reactions analogous to the wt mono-
mer. The apparent resistance to oligomer formation suggested
previously for C173S and C283S based on EM data
(Rodriguez-Casado and Thomas, 2003) was not encountered
in the present study and can be attributed to the higher
concentration of NaCl (440 vs. 100 mM) and the elimination of
EDTA from the storage buffer.
Portal rings were assembled in vitro by elevating the
monomer concentration 100-fold (∼50 mg/mL, 600 μM) at
4 °C, incubating for 24 h at 22 °C, diluting the solution 50-
fold and equilibrating for 6 h on ice. Portal protein was
concentrated using a 50,000 MWCO Centricon concentrator
(Amicon, Danvers, MA). The product was applied to a
HiTrap Q column and eluted with a gradient (NaCl, 100–
660 mM) to separate homogeneous dodecamers, which elute
at ∼650 mM NaCl (Cingolani et al., 2002) from residual
monomers and heterogeneous oligomers, which elute at ∼400
and ∼500 mM NaCl, respectively. The homogeneity of each
preparation was verified by analytical HPSEC (Moore and
Prevelige, 2001; Rodriguez-Casado and Thomas, 2003).
Portal dodecamers were diluted in buffer A and stored at
−80 °C for subsequent use.
Electron microscopy of wt and mutant portals
For EM the in vitro assembled portals at 0.05 mg/mL in
buffer A were mixed with ∼1011 P22 phage/mL, the latter
serving as a size standard. Solutions were applied to a carbon-
coated Formvar layer supported on a copper grid. Specimens
were blotted to remove excess material, fixed for 1 min with
1.0% formaldehyde and stained for 20 s with 2% uranyl acetate
solution. Micrographs of the stained samples were obtained on a
model 1200EX Mark II electron microscope (JEOL USA, Inc.,
Peabody, MA) and recorded on Kodak SO163 film at 60,000×
magnification using an objective lens defocus of ∼1.0 μm. All
of the portal oligomers were stable in 440 mM NaCl for several
days, as judged by HPSEC and EM.
Sedimentation equilibrium analyses of wt and mutant portals
Portal ring size was established by sedimentation equili-
brium analyses of solutions at two concentrations, 0.3 mg/mL
(A280=0.35) and 0.6 mg/mL (A280=0.70), using a model XL-A
analytical ultracentrifuge (Beckman, Fullerton, CA). Each
solution was loaded into three sample channels of a six-channel
centerpiece (12-mm optical path) and analyzed for 24 h at
4000 rpm and 10 °C. The radial distribution was determined by
consecutive A280 measurements at 0.001-cm intervals. The
344 Y. Sun et al. / Virology 365 (2007) 336–345absorbance profiles were fitted globally to a single ideal solute
model using Beckman XL-A software (AutoR1) and assuming
a partial specific volume of 0.7288 cm3/g, as determined by the
SedNTerp program (University of New Hampshire, Durham,
NH). The results were plotted using Origin 6.0 software
(Microcal, Northampton, MA).
In vitro assembly rates of wt and mutant portals
HPSEC was employed to compare time-dependent changes
in the oligomerization states of wt and mutant portals. As noted
above, two tandemly arranged columns were used for optimal
separation of monomeric and dodecameric forms. Typically, a
stock solution of portal monomer was concentrated to 50 μg/μL
and incubated for 40–80 h on ice (4 °C). The low temperature
was employed to decelerate the dodecamerization reaction so
the rate of gp1 assembly could be more precisely evaluated.
Aliquots were removed periodically and diluted to 0.25 μg/μL.
A 10-μL aliquot of the diluted protein solution was injected into
the HPSEC system and peaks were monitored at 280 nm. The
time-dependent distribution of protein between monomeric and
dodecameric states was determined from the corresponding
peak areas.
In vivo activity and in vitro thermostability of wt and mutant
portals
To evaluate the biological activity of each portal variant (wt,
C153S, C173S, C283S and C516S), we carried out comple-
mentation assays using a 1− amber mutant P22 phage to infect
Salmonella cells harboring the corresponding gp1 expressing
plasmid. The five Salmonella-compatible plasmids and the
appropriate P22 phage (1−13− amber mutant) were gifts from
Prof. Peter E. Prevelige (University of Alabama, Birmingham)
(Moore and Prevelige, 2002a). (The 13− mutation enhances
accumulation of progeny phage by preventing cell lysis.) Each
portal-expressing plasmid was transformed by electroporation
into competent Salmonella cells. Each of the five cell lines was
infected with the 1−13− amber mutant (MOI=1), while
simultaneously being induced with 0.46 mM IPTG to express
gp1. (This IPTG concentration allows optimal production of
phage in the complementation assays (Moore and Prevelige,
2002b).) The culture was incubated for 3 h at 37 °C. A 100 μL
aliquot was removed from the culture at time points of 0 and
10 min to establish the quality of the infection and at 3 h to test
for complementation. The cells in each aliquot were lysed, and
the supernatant was titered on a Salmonella suppressor.
Biological activity was quantified by the number of infectious
particles produced during each assay. As a negative control, the
complementation assay was also performed using Salmonella
cells that did not contain the gp1 expressing plasmid. In the
absence of the plasmid, no P22 phage were produced after
infection with the 1−13− ambermutant. Temperature sensitivity
of portal biological activity was assessed by conducting similar
complementation assays at 28, 42 and 45 °C.
To further characterize the in vivo activity of each portal
variant, cell lysates from the complementation assays describedabove were assessed by sucrose gradient separation and SDS–
PAGE. Each cell lysate was applied to a linear sucrose gradient
(5–45%) to separate by weight the soluble components. The
gradients were spun at 35,000 rpm in an SW41 rotor (Beckman,
Fullerton, CA) and an L8-80M ultracentrifuge (Beckman,
Fullerton, CA). The resulting gradients were fractionated (twelve
1-ml fractions) and an aliquot of each fraction was evaluated with
SDS–PAGE and Coomassie blue staining to detect the relative
amounts of portal, scaffolding and capsid proteins.
In vitro thermostabilities of wt and mutant portals – once
incorporated into mature phage particles that had been
assembled at 37 °C – were assessed by titering the phage
following incubations at selected temperatures in the range
4–55 °C.
Raman spectroscopy of wt and mutant portals
Stock solutions of dodecameric portal protein (1 μg/μL in
buffer A) were concentrated to 50 μg/μL in a Centricon-50
device (Amicon, Danvers, MA). Typically, a 5-μL aliquot of the
concentrated solution was transferred to a thin-walled 1-mm
glass capillary (Kimax no. 34502). Raman spectra were excited
at 532 nm (Verdi 5W laser, Coherent Inc., Santa Clara, CA) and
collected using a single-grating spectrograph (model Spex
500M, ISA, Edison, NJ) equipped with a holographic notch
filter, holographic grating and a back-thinned, liquid nitrogen-
cooled charge-coupled device detector (Spectrum One, ISA,
Edison, NJ). Further details of the Raman instrumentation have
been described elsewhere (Movileanu et al., 1999; Rodriguez-
Casado and Thomas, 2003). Sample cells were sealed and
thermostatted (4 °C) for data collections. The Raman spectra
shown below (2520–2620 cm−1) represent averages of 50
exposures of 240 s each, for a total exposure time of ∼3 h per
protocol. All results were duplicated on independently prepared
samples. Laser illumination and related sample handling
resulted in no time-dependent spectral changes, consistent
with earlier findings (Rodriguez-Casado et al., 2001; Rodri-
guez-Casado and Thomas, 2003).
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